University of Minnesota, Department of Urology, Minneapolis, MN 55455, USA.
Eur Urol. 2013 Jun;63(6):1021-7. doi: 10.1016/j.eururo.2012.12.060. Epub 2013 Jan 4.
Lower urinary tract symptoms (LUTS) are common and have been associated with the subsequent diagnosis of prostate cancer (PCa) in population cohorts.
To determine whether the association between LUTS and PCa is due to the intensity of PCa testing after LUTS diagnosis.
DESIGN, SETTING, AND PARTICIPANTS: We prospectively followed a representative, population-based cohort of 1922 men, aged 40-79 yr, from 1990 until 2010 with interviews, questionnaires, and abstracting of medical records for prostate outcomes. Men were excluded if they had a previous prostate biopsy or PCa diagnosis. Self-reported LUTS was defined as an American Urological Association symptom index score >7 (n=621). Men treated for LUTS (n=168) were identified from review of medical records and/or self report. Median follow-up was 11.8 yr (interquartile range: 10.7-12.3).
Associations between self-reported LUTS, or treatment for LUTS, and risk of subsequent prostate biopsy and PCa were estimated using Cox proportional hazard models.
Fifty-five percent of eligible men enrolled in the study. Men treated for LUTS were more likely to undergo a prostate biopsy (hazard ratio [HR]: 2.4; 95% confidence interval [CI], 1.7-3.3). Men younger than 65 yr who were treated for LUTS were more likely to be diagnosed with PCa (HR: 2.3, 95% CI, 1.5-3.5), while men aged >65 yr were not (HR: 0.89, 95% CI, 0.35-1.9). Men with self-reported LUTS were not more likely to be biopsied or diagnosed with PCa. Neither definition of LUTS was associated with subsequent intermediate- to high-risk cancer. The study is limited by lack of histologic or prostate-specific antigen level data for the cohort.
These results indicate that a possible cause of the association between LUTS and PCa is increased diagnostic intensity among men whose LUTS come to the attention of physicians. Increased symptoms themselves were not associated with intensity of testing or diagnosis.
下尿路症状(LUTS)较为常见,并与人群队列中前列腺癌(PCa)的后续诊断有关。
确定 LUTS 与 PCa 之间的关联是否归因于 LUTS 诊断后 PCa 检测的强度。
设计、地点和参与者:我们前瞻性地随访了 1922 名年龄在 40-79 岁的代表性、基于人群的队列,从 1990 年到 2010 年,通过访谈、问卷调查和前列腺结果的病历摘录进行随访。如果男性之前有过前列腺活检或 PCa 诊断,则将其排除在外。自我报告的 LUTS 定义为美国泌尿外科学会症状指数评分>7(n=621)。从病历审查和/或自我报告中确定了因 LUTS 接受治疗的男性(n=168)。中位随访时间为 11.8 年(四分位距:10.7-12.3)。
使用 Cox 比例风险模型估计自我报告的 LUTS 或 LUTS 治疗与随后前列腺活检和 PCa 风险之间的关联。
符合条件的男性中有 55%参加了研究。接受 LUTS 治疗的男性更有可能接受前列腺活检(风险比[HR]:2.4;95%置信区间[CI],1.7-3.3)。年龄小于 65 岁且因 LUTS 接受治疗的男性更有可能被诊断为 PCa(HR:2.3,95%CI,1.5-3.5),而年龄大于 65 岁的男性则不然(HR:0.89,95%CI,0.35-1.9)。自我报告的 LUTS 男性不太可能接受活检或被诊断为 PCa。两种 LUTS 定义均与随后的中高危癌症无关。该研究的局限性在于该队列缺乏组织学或前列腺特异性抗原水平数据。
这些结果表明,LUTS 与 PCa 之间关联的一个可能原因是 LUTS 引起医生注意的男性的诊断强度增加。症状本身的增加与检测或诊断的强度无关。